Department of Advanced Medical and Surgical Sciences, Second Division of Neurology, University of Campania "Luigi Vanvitelli", Naples, Italy.
Research & Innovation srl (R&I Genetics), Padua, Italy.
J Peripher Nerv Syst. 2020 Sep;25(3):308-311. doi: 10.1111/jns.12394. Epub 2020 Jun 11.
Hereditary sensory and autonomic neuropathies (HSAN) encompass a group of peripheral nervous system disorders characterized by remarkable heterogeneity from a clinical and genetic point of view. Mutations in SPTLC1 gene are responsible for HSAN type IA, which usually starts from the second to fourth decade with axonal neuropathy, sensory loss, painless distal ulcerations, and mild autonomic features, while motor involvement usually occur later as disease progresses. Beyond the classic presentation of HSAN type IA, an exceedingly rare distinct phenotype related to SPTLC1 mutations at residue serine 331 (S331) has recently been reported, characterized by earlier onset, prominent muscular atrophy, growth retardation, oculo-skeletal abnormalities, and possible respiratory complications. In this report, we describe clinical, instrumental, and genetic aspects of a 13-year-old Sri Lankan male carrying the rare de novo p.S331Y heterozygous mutation in SPTLC1 gene found by whole exome sequencing. Patient's phenotype partly overlaps with the first case previously reported, however with some additional features not described before. This work represent the second report about this rare mutation and our findings strongly reinforce the hypothesis of a clearly distinct "S331 syndrome", thus expanding the spectrum of SPTLC1-related disorders.
遗传性感觉和自主神经病(HSAN)包括一组周围神经系统疾病,从临床和遗传的角度来看,其具有显著的异质性。SPTLC1 基因突变负责 HSAN 型 IA,其通常从第二至第四十年开始出现轴索性神经病、感觉丧失、无痛性远端溃疡和轻微自主神经特征,而随着疾病的进展,运动受累通常发生较晚。除了 HSAN 型 IA 的经典表现外,最近还报道了一种与 SPTLC1 突变残基丝氨酸 331(S331)相关的极为罕见的独特表型,其特征为发病更早、明显的肌肉萎缩、生长迟缓、眼-骨骼异常和可能的呼吸并发症。在本报告中,我们描述了一位 13 岁的斯里兰卡男性的临床、仪器和遗传方面的情况,他携带通过全外显子组测序发现的 SPTLC1 基因中罕见的从头出现的 p.S331Y 杂合突变。患者的表型部分与之前报道的首例病例重叠,但也有一些以前未描述的其他特征。这项工作是关于这种罕见突变的第二份报告,我们的发现强烈支持了一种明显不同的“S331 综合征”假说,从而扩展了 SPTLC1 相关疾病的范围。